.jpg)
1 hour ago
2
Article content
– Apothecare calls for medical cannabis education to be integrated into clinical training and standard practice, not left to patients to figure out on their own –
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) — New federal guidance on cannabis for medical purposes is drawing attention to a growing gap in Canadian healthcare: patients are increasingly using cannabis to manage symptoms, but often without consistent clinical education, dosing support, or medication-interaction screening.
Article content
Article content
Article content
In January 2026, Health Canada published Information on the Use of Cannabis for Medical Purposes, a consumer-facing guidance document outlining considerations including contraindications, possible drug interactions, dosing and titration principles, and potential adverse effects.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Health Canada also notes that legal cannabis products produced and sold in Canada have not been authorized to treat specific diseases or symptoms and have not been reviewed to determine whether they are safe or effective for those purposes.
Article content
“This is upside-down healthcare,” said Ajay Chahal, PharmD, Co-founder, Apothecare. “Health Canada has done the work to put clear guidance in front of Canadians, but it’s absurd that patients are still forced to become their own medical educators. We’ve created a reality where patients are forced to rely on budtenders for pseudo-clinical advice, with product recommendations for sleep, pain, anxiety, or cancer-related symptoms based on anecdotes like ‘this worked for someone I know.’ That’s not informed care, it’s a symptom of a system that has failed to keep up.”
Article content
Article content
Health Canada states that cannabis use involves health risks that are not yet fully understood and advises Canadians to consult their healthcare provider before starting cannabis for medical purposes.
Article content
“That warning should scare the system into action,” said Anushya Vijayaraghevan, PharmD, Co-founder, Apothecare. “Patients shouldn’t have to gamble with their health to get symptom relief. If a patient is taking antidepressants, blood thinners, seizure medications, or has mental health vulnerabilities, the stakes are real. Yet too often, patients are left navigating product decisions and trial-and-error dosing with little guidance from the clinical system that is supposed to protect them.”
Article content
In response to Health Canada’s guidance, Apothecare is calling for four immediate actions to close the cannabis education gap in Canadian healthcare:
Article content
- Integrate medical cannabis education into core training for physicians, pharmacists, nurses, and allied healthcare providers, with standardized learning outcomes focused on dosing, contraindications, impairment, and drug interactions.
- Establish clinical cannabis counselling as a patient safety standard, ensuring Canadians can access evidence-based guidance that is consistent, medically responsible, and not dependent on retail environments.
- Modernize continuing education requirements through professional bodies so that clinicians can confidently counsel patients and screen for risk factors as cannabis use becomes more common in symptom management.
- Treat cannabis like other pharmacologically active therapies in routine care, including normalizing disclosure, documenting use, and supporting follow-up monitoring instead of leaving patients to trial-and-error.
English (US)